Li CY - Search Results

1

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia.

Kittur J, Knudson RA, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Li CY, Wu W, Ketterling RP, Pardanani A, Tefferi A. Kittur J, et al. Among authors: li cy. Cancer. 2007 Jun 1;109(11):2279-84. doi: 10.1002/cncr.22663. Cancer. 2007. PMID: 17440984 Free article.

2

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera.

Tefferi A, Lasho TL, Schwager SM, Strand JS, Elliott M, Mesa R, Li CY, Wadleigh M, Lee SJ, Gilliland DG. Tefferi A, et al. Among authors: li cy. Cancer. 2006 Feb 1;106(3):631-5. doi: 10.1002/cncr.21645. Cancer. 2006. PMID: 16369984 Free article.

3

Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapy.

Tefferi A, Strand JJ, Lasho TL, Elliott MA, Li CY, Mesa RA, Dewald GW. Tefferi A, et al. Among authors: li cy. Cancer. 2006 Apr 15;106(8):1739-43. doi: 10.1002/cncr.21787. Cancer. 2006. PMID: 16532437 Free article.

4

Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.

Dingli D, Schwager SM, Mesa RA, Li CY, Dewald GW, Tefferi A. Dingli D, et al. Among authors: li cy. Cancer. 2006 May 1;106(9):1985-9. doi: 10.1002/cncr.21868. Cancer. 2006. PMID: 16568439 Free article.

5

Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.

Tefferi A, Huang J, Schwager S, Li CY, Wu W, Pardanani A, Mesa RA. Tefferi A, et al. Among authors: li cy. Cancer. 2007 May 15;109(10):2083-8. doi: 10.1002/cncr.22630. Cancer. 2007. PMID: 17407134 Free article.

6

Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates.

Gangat N, Strand J, Lasho TL, Finke CM, Knudson RA, Pardanani A, Li CY, Ketterling RP, Tefferi A. Gangat N, et al. Among authors: li cy. Eur J Haematol. 2008 Mar;80(3):197-200. doi: 10.1111/j.1600-0609.2007.01003.x. Epub 2007 Dec 7. Eur J Haematol. 2008. PMID: 18081705

7

20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis.

Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL, Mesa R, McClure RF, Li CY, Hanson CA. Tefferi A, et al. Among authors: li cy. Eur J Haematol. 2008 May;80(5):386-90. doi: 10.1111/j.1600-0609.2008.01038.x. Epub 2008 Jan 23. Eur J Haematol. 2008. PMID: 18221390

8

Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis.

Gangat N, Strand JJ, Lasho TL, Li CY, Pardanani A, Tefferi A. Gangat N, et al. Among authors: li cy. Am J Hematol. 2008 Jun;83(6):451-3. doi: 10.1002/ajh.21156. Am J Hematol. 2008. PMID: 18257107 Free article.

9

Risk factors for leukemic transformation in patients with primary myelofibrosis.

Huang J, Li CY, Mesa RA, Wu W, Hanson CA, Pardanani A, Tefferi A. Huang J, et al. Among authors: li cy. Cancer. 2008 Jun 15;112(12):2726-32. doi: 10.1002/cncr.23505. Cancer. 2008. PMID: 18404742 Free article.

10

Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.

Dingli D, Schwager SM, Mesa RA, Li CY, Tefferi A. Dingli D, et al. Among authors: li cy. Cancer. 2006 Feb 1;106(3):623-30. doi: 10.1002/cncr.21644. Cancer. 2006. PMID: 16369987 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,009 results

Search Page

Filters